Cours Beleave Inc. Canadian Securities Exchange
Actions
BE
CA0775611084
Produits pharmaceutiques
CA 2018 | - | CA 2019 | 2,37 3,25 2,17 | Capitalisation | 30,37 M 41,51 M 27,74 M |
---|---|---|---|---|---|
Résultat net 2018 | -12 M -16,4 M -10,96 M | Résultat net 2019 | -33 M -45,11 M -30,14 M | VE / CA 2018 | - |
Trésorerie nette 2018 | 5,2 M 7,11 M 4,75 M | Dette nette 2019 | 10,32 M 14,1 M 9,42 M | VE / CA 2019 | 17 137 012 x |
PER 2018 |
-4,72
x | PER 2019 |
-0,76
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 98,39% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Founder | - | 26/05/00 | |
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Founder | - | 26/05/00 | |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+35,04% | 5,92 Md | |
-15,13% | 4,51 Md | |
-9,75% | 3,15 Md | |
+2,14% | 3,1 Md | |
-6,82% | 2,42 Md | |
+47,87% | 1,97 Md | |
-7,89% | 1,68 Md | |
+0,09% | 1,65 Md | |
-12,97% | 1,53 Md |